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http://www.biomedcentral.com/1471-2261/14/188RESEARCH ARTICLE Open AccessVisit-to-visit blood pressure variability is a marker
of cardiac diastolic function and carotid
atherosclerosis
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Background: The associations between visit-to-visit blood pressure (BP) variability and cardiac function and carotid
atherosclerosis is not clear.
Methods: Study subjects were 144 subjects (80 were female, aged 73 ± 9 years) who underwent echocardiography
and cervical ultrasonography. The ratio of early ventricular filling velocity to early diastolic mitral annular velocity
(E/e’), ejection fraction, left ventricular mass index (LVMI), and maximum intima-media thickness (max-IMT) of the
carotid artery were compared between the highest (high variability) and lowest (low variability) tertiles of the
standard deviation of systolic BP (9.9 ± 3.5 mmHg).
Results: E/e’ and max-IMT were significantly greater in the high variability group than in the low variability group
after adjusting for age, sex, baseline systolic BP, and other covariates (high variability vs. low variability; E/e’: 13.03 ±
5.33 vs. 10.66 ± 3.30, multivariate-adjusted difference (β) = 1.82, 95% confidence interval 0.06–3.58; max-IMT: 1.65 ±
0.43 mm vs. 1.42 ± 0.46 mm, β = 0.20 mm, 95% confidence interval 0.03–0.36 mm). There were no significant
differences in LVMI or ejection fraction.
Conclusion: These results indicate that high visit-to-visit BP variability is associated with diastolic function and carotid
atherosclerosis, and is a possible risk factor for diastolic dysfunction and atherosclerosis.Background
Blood pressure (BP) variability is now considered to be
an important risk factor for cardiovascular diseases
(CVD) [1]. Visit-to-visit BP variability, which is assessed
in several clinical visits and reflects long-term BP vari-
ability, was recently reported to be a strong predictor of
CVD morbidity and mortality independently of BP level
[2-4]. Carotid atherosclerosis, a marker for the risk of
CVD [5], may also be associated with visit-to-visit BP
variability [6]. However, there are limited data regarding
the association between visit-to-visit BP variability and
cardiac function measures [7]; thus, the mechanism
underscoring the association between BP variability and
CVD is unclear. Therefore, this study was conducted to
investigate whether visit-to-visit BP variability is associ-
ated with measures of cardiac function and carotid* Correspondence: rieokada@med.nagoya-u.ac.jp
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raphy and cervical ultrasonography at the same time.
Methods
Study subjects
This study was performed in 144 consecutive subjects
(64 were male and 80 were female; mean age 73 years
[SD, 9 years], range 35–93 years) who underwent echo-
cardiography and cervical ultrasonography at the same
time between September 2011 and August 2013 at
Okada Medical Clinic in Nagoya, Japan. These data were
collected during routine care and were extracted from
medical charts, thus the patients for the examinations
were not randomly collected for this study. The study
subjects were; 15 with the history of coronary heart dis-
eases, 10 with the history of stroke, 42 with diabetes,
118 with hypertension, and 46 with hyperlipidemia. Sys-
tolic and diastolic BP, heart rate, height, and weight at
the time of echocardiography were used as baseline vari-
ables. Blood samples were also taken in the morningLtd. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and
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Fasting plasma glucose, hemoglobin A1c, and serum low-
density lipoprotein cholesterol, uric acid and creatinine
were measured using standard laboratory techniques, and
the estimated glomerular filtration rate was calculated as
previously described [8]. We also recorded whether the
subjects used calcium-channel blockers, angiotensin re-
ceptor blockers, β-blockers, glucose-lowering drugs, or
lipid-lowering drugs. Three subjects were taking low-dose
diuretics for their symptom of heart failure. Histories of
CVD (coronary heart diseases or stroke) were also re-
corded. Subjects with atrial fibrillation or valvular diseases
were excluded from the study. The study was approved by
the ethics committee of Nagoya University Graduate
School of Medicine (approval number 2013–0182) and
the ethics committee of Nagoya Medical Association.
BP measurement and BP variability
We retrospectively reviewed the subjects’ medical re-
cords to retrieve BP values recorded over 1 year before
the echocardiographic examination. BP was measured
in an outpatient clinic every 1 to 3 months using the
conventional cuff method using the standard protocol
of BP measurement by the Japanese Society of Cardio-
vascular Disease Prevention. BP variability was retro-
spectively assessed. The standard deviation (SD) of
systolic BP from 4 to 13 BP measurements was used as
an index of BP variability, as reported in earlier studies
[2,3,6,9-11]. Subjects were classified into tertiles of the
SD of systolic BP as used in the previous study [2], be-
cause the number of study subjects was not enough to
use quartile [9] or decile [3] as used in the other studies.
The lowest tertile was classified as low variability, the
middle tertile as middle variability, and the highest ter-
tile as high variability.
Echocardiographic examination
Echocardiographic examinations were performed by a sin-
gle sonographer who assessed cardiac structural changes
and cardiac function. Two-dimensional (2D) echocardiog-
raphy and M-mode echocardiography were performed
using high-resolution ultrasound (Apron EUB-7000HV;
Hitachi Medical Corporation, Tokyo, Japan). Left ventricu-
lar (LV) diastolic function was assessed by transmittal
pulse-wave Doppler to measure mitral inflow early (E) and
late (A) diastolic filling velocities, E/A ratio, and tissue
Doppler imaging parameters, including the early diastolic
mitral annular velocity (e’), which was measured on the
lateral side of mitral annulus. The E/e’ ratio was measured
as an index of LV filling pressure. Diastolic dysfunction
was defined as E/e’ ≥15 [12]. The left atrial dimension was
measured on 2D-guided M-mode echocardiographic im-
ages of the base of the heart obtained in the parasternal
short-axis view. Ejection fraction was measured using aquantitative 2D method (biplane Simpson method of
disks) [13]. The LV mass index (LVMI) was calculated
using Devereux’s equation and was adjusted for body sur-
face area [14].
Arterial stiffness was assessed by measuring the ca-
rotid intima-media thickness (IMT) just after echocardi-
ography by high-resolution ultrasound, as described
above, with a 7.5-MHz linear array transducer. The max-
imum IMT (max-IMT) was defined as the single thickest
wall of the near and far right or left walls of the com-
mon carotid artery, bulbus, and internal carotid artery,
including plaques, as a marker of carotid atherosclerosis
[5]. The lesion was scanned bilaterally in longitudinal
and transverse projections. The max-IMT was measured
at the site of the most advanced atherosclerotic lesion
that exhibited the greatest distance between the lumen-
intimal interface and the media-adventitia interface.
Carotid atherosclerosis was defined as a focal wall thick-
ness of >1.5 mm [15].
Statistical analyses
Clinical, echocardiography, and cervical ultrasonography
variables were compared among the tertile groups of BP
variability using analysis of variance for continuous vari-
ables or χ2 tests for dichotomous variables. Variables
that showed statistically significant differences among
the three groups were then included in multivariate ana-
lyses. β coefficients (the differences between the highest
or middle tertile and the lowest tertile) and 95% confi-
dence intervals (CI) were calculated for each variable by
linear regression with adjustment for age (continuous),
sex, baseline systolic BP (continuous), use of antihyper-
tensive drugs, and history of CVD. Odds ratios and 95%
CIs were calculated for the prevalence of diastolic dys-
function and carotid atherosclerosis by unconditional
logistic regression with adjustment for the same covari-
ates. Values of P < 0.05 in adjusted models were consid-
ered statistically significant. All analyses were performed
using STATA software version 9 (Stata Corp, College
Station, TX, USA).
Results
BP was measured for 9.5 ± 2.9 times during one year
(range 4 to 13 times), and mean systolic BP was 130 ±
10 mmHg; the lowest tertile (SD <8.29 mmHg), the mid-
dle tertile (SD 8.29-10.99 mmHg), and the highest tertile
(SD >10.99 mmHg). The clinical, echocardiography, and
cervical ultrasonography variables for the study subjects
are summarized by BP variability level in Tables 1 and 2.
The high BP variability group tended to be older, had a
higher proportion of female subjects, and had higher
lipid levels compared with the other groups of subjects,
although the differences in these are not statistically sig-
nificant. The mean ejection fraction was 57%; two-thirds
Table 1 Characteristics of subjects according to the level of blood pressure variability (n = 144)
Blood pressure variability
Low variability Middle variability High variability P value
n 48 48 48
Age (years) 72.3 ± 9.1 70.8 ± 8.5 74.7 ± 8.7 0.101a
Male 24 (50.0%) 21 (43.8%) 19 (39.6%) 0.586b
Blood pressure measurements (times) 9.1 ± 3.1 9.5 ± 2.6 9.7 ± 2.8 0.569a
Systolic blood pressure (mmHg) 130.2 ± 10.1 132.0 ± 12.2 131.5 ± 16.9 0.801a
Diastolic blood pressure (mmHg) 72.1 ± 11.0 72.8 ± 11.8 71.2 ± 10.3 0.780a
Pulse pressure (mmHg) 58.1 ± 12.3 59.2 ± 11.5 60.3 ± 15.4 0.728a
Heart rate (beats/min) 73.8 ± 9.8 70.5 ± 6.8 72.3 ± 6.9 0.248a
Antihypertensive medication 33 (68.8%) 38 (79.2%) 41 (85.4%) 0.140b
Calcium-channel blocker 27 (56.3%) 30 (62.5%) 34 (70.8%) 0.331b
Renin-angiotensin antagonist 20 (41.7%) 19 (39.6%) 24 (50.0%) 0.553b
β-blocker 6 (12.5%) 9 (18.8%) 3 (6.3%) 0.180b
Fasting plasma glucose (mg/dL) 116.3 ± 41.5 118.8 ± 47.8 115.5 ± 38.9 0.923a
HbA1c (%) 6.12 ± 0.94 5.98 ± 0.80 5.82 ± 0.60 0.173a
Glucose-lowering medication 8 (16.7%) 8 (16.7%) 8(16.7%) 1.000b
LDL-cholesterol (mg/dl) 114.2 ± 24.0 118.0 ± 28.2 124.6 ± 25.5 0.146a
Lipid-lowering medication 13 (27.1%) 16 (33.3%) 17 (35.4%) 0.660b
Uric acid (mg/dL) 5.50 ± 1.26 5.25 ± 1.29 5.38 ± 1.32 0.643a
Body mass index (kg/m2) 24.13 ± 3.87 24.03 ± 3.20 24.19 ± 3.56 0.977a
eGFR (ml/min/1.73 m2) 68.0 ± 19.4 67.5 ± 15.9 64.9 ± 17.8 0.667a
Proteinuria 4 (8.3%) 6 (12.5%) 7 (14.6%) 0.627b
Cardiovascular disease 9 (18.8%) 8 (16.7%) 7 (14.6%) 0.861b
Data are means ± standard deviation or n (%). Low, middle, and high variability are defined as the lowest (<8.29 mmHg), middle (8.29–10.99 mmHg), and highest
(>10.99 mmHg) tertiles of the standard deviation of systolic blood pressure, respectively.
LDL-cholesterol, low-density lipoprotein cholesterol; eGFR, estimated glomerular filtration rate.
aAnalysis of covariance; bχ2 test.
Table 2 Echocardiography, and cervical ultrasonography characteristics of subjects according to the level of blood
pressure variability (n = 144)
Blood pressure variability
Low variability Middle variability High variability P valuea
n 48 48 48
Left atrium diameter (mm) 37.3 ± 5.0 36.4 ± 4.6 37.6 ± 6.2 0.541
E (m/s) 0.53 ± 0.13 0.59 ± 0.19 0.57 ± 0.20 0.162
A (m/s) 0.71 ± 0.15 0.77 ± 0.17 0.77 ± 0.19 0.153
e’ (m/s) 0.054 ± 0.019 0.053 ± 0.012 0.048 ± 0.019 0.189
E/A 0.77 ± 0.26 0.80 ± 0.29 0.76 ± 0.29 0.845
E/e’ 10.66 ± 3.30 11.60 ± 3.36 13.03 ± 5.33 0.019
LVMI (mm) 139.0 ± 27.3 137.0 ± 23.6 148.1 ± 30.7 0.108
Ejection fraction (%) 58.3 ± 9.1 58.2 ± 6.8 57.5 ± 8.1 0.859
Max-IMT (mm) 1.42 ± 0.46 1.36 ± 0.37 1.65 ± 0.43 0.003
Data are means ± standard deviation or n (%). Low, middle, and high variability are defined as the lowest (<8.29 mmHg), middle (8.29–10.99 mmHg), and highest
(>10.99 mmHg) tertiles of the standard deviation of systolic blood pressure, respectively.
E, early ventricular filling velocity; A, late ventricular filling velocity; e’, early diastolic mitral annular velocity; LVMI, left ventricular mass index; max-IMT, maximum
intima-media thickness.
aAnalysis of covariance.
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fraction ≥55%). The LVMI was greatest in the high BP
variability group, although this difference was not statis-
tically significant. There were no differences in ejection
fraction among the three groups.
Because E/e’ and max-IMT were significantly different
between the BP variability groups (P <0.05 by Tukey
method), multivariate analyses were performed to exam-
ine the associations between BP variability and E/e’ and
max-IMT. Both E/e’ and max-IMT were significantly
greater in the high BP variability group than in the low
BP variability group also in the multivariate models
(high BP variability, middle BP variability vs. low BP
variability; E/e’: 13.03 ± 5.33, 11.60 ± 3.36 vs. 10.66 ± 3.30,
multivariate-adjusted difference (β) = 1.82, 95% CI 0.06–
3.58 for high BP variability and β = 0.92, 95% CI −0.44–
2.29 for middle BP variability; max-IMT 1.65 ± 0.43 mm,
1.36 ± 0.37 mm vs. 1.42 ± 0.46 mm, β = 0.20 mm, 95% CI
0.03–0.36 mm for high BP variability and β = −0.02 mm,
95% CI −0.17–0.13 mm for middle BP variability).
Additionally, the prevalence rates of diastolic dysfunction
and carotid atherosclerosis were greater in the high BP
variability group than in the low BP variability group. The
risk of carotid atherosclerosis was significantly greater in
the high BP variability group compared with the low vari-
ability group (69% vs. 38%, OR 4.93, 95% CI 1.75–13.91) in
the multivariate model. Also, the risk of diastolic dysfunc-
tion was greater in the high BP variability group compared
with the low variability group although it was not statisti-
cally significant after adjustment (29% vs. 10%; OR 2.71,
95% CI 0.78–9.38) (Table 3).
Discussion
To the best of our knowledge, this was the first study to
reveal that greater visit-to-visit BP variability is signifi-
cantly associated with both decreased diastolic function
and carotid atherosclerosis independently of mean
BP. These findings may provide new insights into theTable 3 Prevalence of diastolic dysfunction and carotid ather
variabilit
Blood pressure variability
Low variability Middle variability
Crude OR
n (%) OR n (%) (95% CI)
Diastolic dysfunction
E/e’ <15 43 (89.6) 41 (85.4)
E/e’ ≥15 5 (10.4) 1 (reference) 7 (14.6) 1.47 (0.43–5
Carotid atherosclerosis
Max-IMT ≤1.5 mm 30 (62.5) 29 (60.4)
Max-IMT >1.5 mm 18 (37.5) 1 (reference) 19 (39.6) 1.09 (0.48–2
OR, odds ratio; CI, confidence interval; E/e’, early ventricular filling velocity/early dias
aAdjusted for age, sex, baseline systolic blood pressure, use of antihypertensive drumechanism underlying the relationship between visit-to-
visit BP variability and CVD.
Recent data suggest that BP variability is a strong
prognostic factor for stroke, coronary heart disease, and
all-cause mortality [1-4]. There are several methods to
measure BP variability; visit-to-visit BP variability repre-
sents long-term BP variability while 24-h BP variability
assessed by ambulatory blood pressure monitoring rep-
resents short-term BP variability. Prior studies showed
that greater visit-to-visit BP variability was independ-
ently associated with increased risk of coronary heart
disease [4], stroke [3], and all-cause mortality [2]. Visit-
to-visit BP variability may be a predictor of CVD com-
pared with mean BP [3] or 24-h BP variability [16].
Thus, visit-to-visit BP variability is a useful and easily
measurable marker of CVD.
This study showed that visit-to-visit BP variability was
associated with carotid IMT. Carotid IMT is a well-
established marker of subclinical atherosclerosis, and it
is strongly associated with the risk of future CVD events
including coronary heart disease and stroke [5]. Recent
studies have demonstrated that visit-to-visit BP variabil-
ity is also associated with aortic distensibility [9] and
endothelial dysfunction [10], which are also markers of
subclinical atherosclerosis [17,18]. Higher 24-h BP vari-
ability was reported to be a strong predictor of IMT
increase [19], and one study demonstrated an associ-
ation between higher visit-to-visit BP variability and
greater IMT [6]. Fluctuations in BP cause a vascular
damage [11]. Steep BP variations increase the oscillatory
shear stress in the vessel wall of medium and large arter-
ies. This enhances the traumatic effect of intravascular
pressures on the vessel wall that ultimately results in the
progression of atherosclerosis [20,21]. Meanwhile im-
pairments in baroreflex sensitivity caused by structural
changes of blood vessels increases BP variability [22].
These mechanisms may explain the relationship between
BP variability and IMT.osclerosis according to the level of blood pressure
High variability
Adjusted ORa Crude OR Adjusted ORa
(95% CI)a n (%) (95% CI) (95% CI)a
34 (70.8)
.00) 1.33 (0.36–4.92) 14 (29.2) 3.54 (1.16-10.81) 2.71 (0.78–9.38)
15 (31.2)
.48) 1.47 (0.53–4.08) 33 (68.8) 3.67 (1.58-8.54) 4.93 (1.75–13.91)
tolic mitral annular velocity; IMT, intima–media thickness.
gs, and history of cardiovascular disease.
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of heart failure with preserved ejection fraction [23].
Previous studies revealed that diastolic dysfunction was
a predictor of CVD mortality [24], and had a prognostic
significance similar to systolic dysfunction [25]. Little is
known about the association between BP variability and
diastolic function. To our knowledge, only one study of
40 hypertensive patients has revealed an association be-
tween visit-to-visit BP variability and diastolic function
[8]. This relationship might be mediated by impaired
baroreflex sensitivity. Impaired baroreflex sensitivity
caused by sinoaortic denervation resulted in an increase
in BP variability and diastolic dysfunction in an animal
model [26,27], which suggests that sympathetic modula-
tion of BP can cause diastolic dysfunction. Another
mechanism might involve the association between arter-
ial stiffening and diastolic dysfunction (that is, arterial–
ventricular coupling) [28,29], which was reported to
cause heart failure with preserved ejection fraction
[30,31]. Because cardiac relaxation is delayed if cardiac
afterload is increased by arterial stiffening [28], some
studies have shown that greater carotid IMT is associ-
ated with diastolic dysfunction [32,33].
The LVMI was greater in subjects with higher BP vari-
ability, which was consistent with the former study [34],
although it was not statistically significant. And systolic
function was not associated with BP variability. Diastolic
dysfunction precedes LV hypertrophy in the develop-
ment of hypertension [35], and diastolic dysfunction pre-
cedes systolic dysfunction in the process subclinical
atherosclerosis [33]. Thus, the association between BP
variability and diastolic function may precede the devel-
opment of LV hypertrophy and systolic dysfunction.
Several limitations of this study should be mentioned.
First, because of the relatively small number of subjects,
we could not perform analyses after stratifying the sub-
jects according to their age or the presence of hyperten-
sion. Most of the prior studies that showed associations
between BP variability and diastolic function or IMT
were performed in elderly subjects with hypertension
[6,7], and the effects of BP variability might be differ be-
tween age groups or sexes [36]. Further studies are
needed to examine whether the associations between
BP variability and diastolic function or IMT are also
apparent in middle-aged subjects or non-hypertensive
subjects. Also, the study with a larger sample size is re-
quired to confirm the result of the multivariable adjust-
ments. The strength of the association became weaker
for diastolic dysfunction and stronger for carotid athero-
sclerosis after adjustment, which should be considered
in the future studies. Second, the number of visits to as-
sess BP variability was rather small, the number of visits
was not the same for all the subjects in this study, and
the interval between visits were not the same, whichinfluence BP variability [37]. The study with a larger
number of visits and the same number of visits for all
the subjects is needed for the better assessment of BP
variability, especially in the study with small number of
subjects. Third, these data were collected during routine
care and were extracted from medical charts, thus the
patients for the examinations were not randomly col-
lected for this study, which may affect the study results.
Fourth, considering the cross-sectional design of this
study, we could not determine whether treating patients
with high BP variability can prevent the progression to
diastolic dysfunction and carotid atherosclerosis. This
possibility should be examined in longitudinal studies.
Conclusions
Visit-to-visit BP variability recorded over 1 year was as-
sociated with cardiac diastolic function and carotid ath-
erosclerosis. In addition to other well-defined risk
factors, we suggest that visit-to-visit BP variability is
considered as a marker for the development of diastolic
dysfunction and atherosclerosis. Measurements of car-
diac function and carotid atherosclerosis may be war-
ranted in subjects with high BP variability.
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